Literature DB >> 2449820

A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks.

O Gelisken1, F Hendrikse, A F Deutman.   

Abstract

We treated 30 eyes (24 patients) with angioid streaks and neovascular membranes using light coagulation. Of 30 eyes, 16 showed either ameliorated or unchanged visual acuity. Twelve of the remaining 14 eyes retained a visual acuity of 20/200 or better. In 11 patients, the fellow untreated eye showed central macular degeneration with loss of central vision. The follow-up period ranged from two months to 16 years (mean, 3.4 years).

Entities:  

Mesh:

Year:  1988        PMID: 2449820     DOI: 10.1016/0002-9394(88)90014-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks.

Authors:  Luis Arias; Octavio Pujol; Marcos Rubio; Jose Caminal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-14       Impact factor: 3.117

2.  Long-term follow-up of choroidal neovascularization secondary to angioid streaks: case series and literature review.

Authors:  Saba Al-Rashaed; J Fernando Arevalo
Journal:  Clin Ophthalmol       Date:  2012-07-05

3.  Angioid streaks, clinical course, complications, and current therapeutic management.

Authors:  Ilias Georgalas; Dimitris Papaconstantinou; Chrysanthi Koutsandrea; George Kalantzis; Dimitris Karagiannis; Gerasimos Georgopoulos; Ioannis Ladas
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

4.  Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks.

Authors:  Jun Mok Lee; Woo Ho Nam; Ha Kyoung Kim
Journal:  Korean J Ophthalmol       Date:  2007-09

5.  To laser or not?

Authors:  Vishal Govindhari; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.